Elanco Animal Health (ELAN) Other Operating Expenses (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Other Operating Expenses came in at -$9.0 million in Q1 2026, up 25.0% year-on-year from -$7.2 million in Q1 2025, and up 52.63% quarter-over-quarter from -$19.0 million in Q4 2025.
Elanco Animal Health (ELAN) Other Operating Expenses (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Other Operating Expenses across 10 years of filings, most recently posting -$9.0 million for Q1 2026.
- Other Operating Expenses for Q1 2026 came in at -$9.0 million, up 25.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$39.0 million (down 85.71% YoY), and the FY2025 annual result was -$19.0 million, down 5.56% from the prior year.
- Other Operating Expenses came in at -$9.0 million for Q1 2026 at Elanco Animal Health, up from -$19.0 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $707.0 million in Q1 2022 to a low of -$75.0 million in Q4 2023.
- The 5-year median for Other Operating Expenses is -$2.0 million (2024), against an average of $262.9 million.
- Across the five-year window, Other Operating Expenses surged 92.0% in 2024 and plunged 450.0% in 2025, its largest moves.
- Elanco Animal Health's Other Operating Expenses stood at $667.0 million in 2022, then tumbled by 111.24% to -$75.0 million in 2023, then soared by 92.0% to -$6.0 million in 2024, then plunged by 216.67% to -$19.0 million in 2025, then soared by 52.63% to -$9.0 million in 2026.
- The last three Other Operating Expenses figures came in at -$9.0 million (Q1 2026), -$19.0 million (Q4 2025), and -$11.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.00 Mn |
| Dec 31, 2025 | -19.00 Mn |
| Jun 30, 2025 | -11.00 Mn |
| Mar 31, 2025 | -12.00 Mn |
| Dec 31, 2024 | -6.00 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -9.00 Mn |
| Dec 31, 2023 | -75.00 Mn |
| Jun 30, 2023 | 667.00 Mn |
| Mar 31, 2023 | 701.00 Mn |
| Dec 31, 2022 | 667.00 Mn |
| Sep 30, 2022 | 668.00 Mn |
| Jun 30, 2022 | 678.00 Mn |
| Mar 31, 2022 | 707.00 Mn |
| Dec 31, 2021 | 702.00 Mn |
| Sep 30, 2021 | 714.00 Mn |
| Jun 30, 2021 | 731.00 Mn |
| Mar 31, 2021 | 776.00 Mn |
| Dec 31, 2020 | 803.70 Mn |